Tag: Pharmaceuticals

vincerx
United States

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a … Continue reading Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Impact Newswire
Sanofi
Europe

Sanofi and Orano join forces to develop next-generationradioligand medicines

Press Release – Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines. Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will … Continue reading Sanofi and Orano join forces to develop next-generationradioligand medicines

Impact Newswire
ANEBULO PHARMACEUTICALS
United States

Anebulo Pharmaceuticals Announces New CEO

October 06, 2023 04:06 PM Eastern Daylight Time AUSTIN, Texas – Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo”), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (“ACI”), today announced that Richie Cunningham has been appointed as Anebulo’s Chief Executive Officer, replacing Simon Allen. “Anebulo has positioned ANEB-001 for success and I look forward to working with the leadership team and board … Continue reading Anebulo Pharmaceuticals Announces New CEO

Impact Newswire